A U.K. pharma trade group suspended Novo Nordisk’s membership for two years after marketing efforts for its obesity drug were deemed a breach of the group’s standards. ABPI said it took the action ...
Amid its two-year suspension from the Association of the British Pharmaceutical Industry, the U.K.’s pharma trade group, following a series of breaches of the organization’s code of practice, Novo ...
A British Medical Journal (BMJ) investigation featuring data analysis from Dr. Piotr Ozieranski at the University of Bath and Dr. Shai Mulinari from Lund University, Sweden reveals processing times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results